Necrotic and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro

Cell Biochemistry and Function

Volumn 32, Issue 1, 2014, Pages 77-86

  Fujita, Hirofumi ^a   Yamamoto, Masanao ^a   Ogino, Tetsuya ^a,e   Kobuchi, Hirotsugu ^a   Ohmoto, Naoko ^a   Aoyama, Eriko ^b   Oka, Takashi ^a   Nakanishi, Tohru ^c   Inoue, Keiji ^d   Sasaki, Junzo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c SHUJITSU UNIVERSITY   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Calcification; Mesenchymal stem cell; Necrosis; Osteoblast; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; AMINOLEVULINIC ACID; ASCORBIC ACID; CALCIUM; CASPASE 3; CASPASE INHIBITOR; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; MESSENGER RNA; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; TIRON; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; ARTICLE; ATOMIC ABSORPTION; CALCIFICATION; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CHROMATIN CONDENSATION; CULTURE MEDIUM; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MESENCHYMAL STEM CELL; OSTEOBLAST; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

APOPTOSIS; CALCIFICATION; MESENCHYMAL STEM CELL; NECROSIS; OSTEOBLAST; REACTIVE OXYGEN SPECIES;

1,2-DIHYDROXYBENZENE-3,5-DISULFONIC ACID DISODIUM SALT; ACETYLCYSTEINE; AMINO ACID CHLOROMETHYL KETONES; ANTIOXIDANTS; APOPTOSIS; CALCIFICATION, PHYSIOLOGIC; CASPASE 3; CASPASE INHIBITORS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENZYME ACTIVATION; HUMANS; MESENCHYMAL STROMAL CELLS; NECROSIS; OSTEOBLASTS; REACTIVE OXYGEN SPECIES;

EID: 84891835898     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2974     Document Type: Article

References (52)

1. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 2005; 10: 822-837.
2. Drabek K, van de Peppel J, Eijken M, van Leeuwen JP. GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release. J Bone Miner Res 2011; 26: 2045-2051. doi:10.1002/jbmr.435.
3. Boskey AL. Biomineralization: conflicts, challenges, and opportunities. J Cell Biochem Suppl 1998; 30-31: 83-91.
4. Wuthier RE, Lipscomb GF. Matrix vesicles: structure, composition, formation and function in calcification. Front Biosci 2012; 17: 2812-2902.
5. Hessle L, Johnson KA, Anderson HC, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002; 99: 9445-9449. doi:10.1073/pnas.142063399.
6. Xiao Z, Camalier CE, Nagashima K, et al. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J Cell Physiol 2007; 210: 325-335. doi:10.1002/jcp.20826.
7. Kirsch T, Wang W, Pfander D. Functional differences between growth plate apoptotic bodies and matrix vesicles. J Bone Miner Res 2003; 18: 1872-1881. doi:10.1359/jbmr.2003.18.10.1872.
8. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423: 332-336. doi:10.1038/nature01657.
9. Nagase Y, Iwasawa M, Akiyama T, et al. Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts. J Biol Chem 2009; 284: 36659-36669. doi:10.1074/jbc.M109.016915.
10. Kirsch T. Determinants of pathological mineralization. Curr Opin Rheumatol 2006; 18: 174-180. doi:10.1097/01.bor.0000209431.59226.46.
11. Hashimoto S, Ochs RL, Rosen F, et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 1998; 95: 3094-3099.
12. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97: 2307-2315.
13. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062.
14. Cliff WJ. The aortic tunica media in aging rats. Exp Mol Pathol 1970; 13: 172-189.
15. Klotz O. Studies upon calcareous degeneration: I. The process of pathological calcification. J Exp Med 1905; 7: 633-674.
16. Rockley GJ. A case of renal cortical necrosis with dystrophic calcification demonstrated at the Postgraduate Medical School of London. Br Med J 1965; 2: 633-636.
17. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16: 663-669. doi:10.1016/j.ceb.2004.09.011.
18. Zimmermann B. Occurrence of osteoblast necroses during ossification of long bone cortices in mouse fetuses. Cell Tissue Res 1994; 275: 345-353.
19. Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10: 221-237. doi:10.1038/nrd3373.
20. Byon CH, Javed A, Dai Q, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008; 283: 15319-15327. doi:10.1074/jbc.M800021200.
21. Morita K, Miyamoto T, Fujita N, et al. Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification. J Exp Med 2007; 204: 1613-1623. doi:10.1084/jem.20062525.
22. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
23. Shih YR, Tseng KF, Lai HY, Lin CH, Lee OK. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 2011; 26: 730-738. doi:10.1002/jbmr.278.
24. Gentleman E, Swain RJ, Evans ND, et al. Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater 2009; 8: 763-770. doi:10.1038/nmat2505.
25. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem 2009; 284: 4897-4904. doi:10.1074/jbc.M805432200.
26. Moioli EK, Hong L, Mao JJ. Inhibition of osteogenic differentiation of human mesenchymal stem cells. Wound Repair Regen 2007; 15: 413-421. doi:10.1111/j.1524-475X.2007.00244.x.
27. Zhang X, Ting K, Bessette CM, et al. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice. J Bone Miner Res 2011; 26: 777-791. doi:10.1002/jbmr.267.
28. Fujita H, Kurokawa K, Ogino T, et al. Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-kappaB ligand and apoptosis in mesenchymal stem cells. Basic Clin Pharmacol Toxicol 2011; 109: 78-84. doi:10.1111/j.1742-7843.2011.00685.x.
29. Li H, Ambade A, Re F. Cutting edge: necrosis activates the NLRP3 inflammasome. J Immunol 2009; 183: 1528-1532. doi:10.4049/jimmunol.0901080.
30. Fujita H, Utsumi T, Muranaka S, et al. Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B. Biochem Pharmacol 2005; 69: 1773-1784. doi:10.1016/j.bcp.2005.03.006.
31. Puchtler H, Meloan SN, Terry MS. On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 1969; 17: 110-124.
32. Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 2007; 41: 462-473. doi:10.1016/j.bone.2007.04.191.
33. Amo T, Kawanishi N, Uchida M, et al. Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937. Cell Biochem Funct 2009; 27: 503-515. doi:10.1002/cbf.1603.
34. Fujita H, Shiosaka M, Ogino T, et al. Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1. Brain Res 2008; 1206: 1-12. doi:10.1016/j.brainres.2008.01.081.
35. Zielonka J, Kalyanaraman B. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 2010; 48: 983-1001. doi:10.1016/j.freeradbiomed.2010.01.028.
36. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 1995; 270: 9420-9428.
37. Fritz JA, Behm CA. CUTI-1: a novel tetraspan protein involved in C. elegans CUTicle formation and epithelial integrity. PLoS One 2009; 4: e5117. DOI: 10.1371/journal.pone.0005117
38. Park JM, Ng VH, Maeda S, Rest RF, Karin M. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med 2004; 200: 1647-1655. doi:10.1084/jem.20041215.
39. Tao J, Critser ES, Critser JK. Evaluation of mouse sperm acrosomal status and viability by flow cytometry. Mol Reprod Dev 1993; 36: 183-194. doi:10.1002/mrd.1080360209.
40. Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y. Oxidative stress in bone remodelling and disease. Trends Mol Med 2009; 15: 468-477. doi:10.1016/j.molmed.2009.08.004.
41. Kim H, Kim HJ, Lee K, et al. Alpha-lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med 2011. DOI: 10.1111/j.1582-4934.2011.01294.x
42. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 2009; 47: 333-343. doi:10.1016/j.freeradbiomed.2009.05.004.
43. Eisenhoffer GT, Loftus PD, Yoshigi M, et al. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. Nature 2012; 484: 546-549. doi:10.1038/nature10999.
44. Yu X, Cohen DM, Chen CS. miR-125b is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Stem Cells 2012; 30: 956-964. doi:10.1002/stem.1064.
45. Zimmermann B, Wachtel HC, Noppe C. Patterns of mineralization in vitro. Cell Tissue Res 1991; 263: 483-493.
46. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 1998; 13: 793-802. doi:10.1359/jbmr.1998.13.5.793.
47. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998; 13: 581-589. doi:10.1359/jbmr.1998.13.4.581.
48. Ebert R, Zeck S, Krug R, et al. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation. Bone 2009; 44: 858-864. doi:10.1016/j.bone.2009.01.009.
49. Kupcsik L, Meurya T, Flury M, Stoddart M, Alini M. Statin-induced calcification in human mesenchymal stem cells is cell death related. J Cell Mol Med 2009; 13: 4465-4473. doi:10.1111/j.1582-4934.2008.00545.x.
50. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001; 280: 874-877. doi:10.1006/bbrc.2000.4232.
51. Ding J, Ghali O, Lencel P, et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 2009; 84: 499-504. doi:10.1016/j.lfs.2009.01.013.
52. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-2642.